We are live on ! Find out more
HP

Hikari Power Portfolio holdings

AUM $855M Turnover 22.64%
1-Year Est. Return 14.24%
This Fund
S&P 500
This Quarter Est. Return
+7.33%
1 Year Est. Return
+14.24%
3 Year Est. Return
+53.45%
5 Year Est. Return
+75.51%
10 Year Est. Return
+220.8%
AUM
$964M
AUM Growth
+$37.2M
Cap. Flow
-$29.4M
Cap. Flow %
-3.05%
Top 10 Hldgs %
63.3%
Holding
123
New
7
Increased
13
Reduced
13
Closed
12
Avg Time Held
2.2 years
Top 10 Avg Time Held
2.5 years
Top 20 Avg Time Held
2.5 years

Top Sells

Rank Stock Value
1
GE icon
GE Aerospace
GE
+$7.61M
2
NVO icon
Novo Nordisk
NVO
+$5.31M
3
GILD icon
Gilead Sciences
GILD
+$4.07M
4
PG icon
Procter & Gamble
PG
+$4.02M
5
BIIB icon
Biogen
BIIB
+$3.68M

Sector Composition

Rank Sector Weight
1 Financials 41.99%
2 Healthcare 19.01%
3 Miscellaneous 12%
4 Industrials 7.19%
5 Materials 6.1%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
HPQ icon
101
HP
HPQ
$27.1B
$201K 0.02%
+9,790
New +$185K
2019 Q4
0 quarters
SRRA
102
DELISTED
Sierra Oncology, Inc. Common Stock
SRRA
$171K 0.02%
12,503
– –
2018 Q4
4 quarters
EAF icon
103
GrafTech
EAF
$185M
$164K 0.02%
1,415
– –
2019 Q2
2 quarters
GME icon
104
GameStop
GME
$13.5B
$134K 0.01%
88,480
– –
2019 Q2
2 quarters
MIK
105
DELISTED
Michaels Stores, Inc
MIK
$125K 0.01%
15,450
– –
2018 Q2
6 quarters
SPHS
106
DELISTED
Sophiris Bio, Inc.
SPHS
$111K 0.01%
300,900
– –
2018 Q3
5 quarters
FTSI
107
DELISTED
FTS International, Inc. Common Stock
FTSI
$19K ﹤0.01%
932
– –
2019 Q2
2 quarters
CL icon
108
Colgate-Palmolive
CL
$75B
– –
-13,000
Closed -$956K –
DNOW icon
109
DNOW Inc
DNOW
$2.83B
– –
-55,675
Closed -$639K –
EOLS icon
110
Evolus
EOLS
$469M
– –
-68,500
Closed -$1.07M –
IFF icon
111
International Flavors & Fragrances
IFF
$23.1B
– –
-5,420
Closed -$665K –
MRSN icon
112
DELISTED
Mersana Therapeutics
MRSN
– –
-3,610
Closed -$143K –
NOV icon
113
NOV
NOV
$6.75B
– –
-43,900
Closed -$931K –
RTX icon
114
RTX Corp
RTX
$261B
– –
-23,756
Closed -$2.04M –
TGTX icon
115
TG Therapeutics
TGTX
$8.26B
– –
-50,000
Closed -$281K –
RVNC icon
116
DELISTED
Revance Therapeutics, Inc.
RVNC
– –
-80,100
Closed -$1.04M –
CALA
117
DELISTED
Calithera Biosciences, Inc
CALA
– –
-2,500
Closed -$155K –
MDR
118
DELISTED
McDermott International
MDR
– –
-75,600
Closed -$153K –
CELG
119
DELISTED
Celgene Corp
CELG
– –
-2,080
Closed -$207K –

Similar funds

Hikari Power's Q4 2019 Portfolio in Review

As of Q4 2019, Hikari Power held 123 positions worth $964M, up 4% from $927M the previous quarter. Its ten largest holdings account for 63% of the portfolio.

Hikari Power withdrew a net $29.4M in Q4 2019, closing 12 positions and reducing 13 holdings. Its most notable exit was RTX Corp, an estimated $2.04M position sold in full.

By sector, the portfolio is most concentrated in Financials at 42% of assets, up from 40% a quarter earlier, followed by Healthcare and Miscellaneous.

Against the trend, Hikari Power opened a new position in Paramount Global Class B worth $325K.

  • Hikari Power's largest Q4 2019 buy was Paramount Global Class B: 7,755 shares worth $325K.
  • Hikari Power added most to Berkshire Hathaway Class A in Q4 2019, an estimated $3.26M increase.
  • Hikari Power's biggest Q4 2019 reduction was GE Aerospace, cutting an estimated $7.61M.
  • Hikari Power fully exited RTX Corp in Q4 2019, selling an estimated $2.04M.
  • Hikari Power's ten largest holdings make up 63% of its $964M portfolio in Q4 2019.
  • Hikari Power opened 7 new positions and closed 12 in Q4 2019.
  • Hikari Power's portfolio value rose 4% quarter-over-quarter to $964M.

Based on Hikari Power's 13F filing for Q4 2019, filed 4 Feb 2020.